Etoposide injection: Clinical Trials

4 trials of Etoposide injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 active not recruiting, 1 recruiting. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Not yet recruiting 2, Active not recruiting 1, Recruiting 1

Follow Etoposide injection: new trials by email Literature Review of Etoposide injection trials Research Report on Etoposide injection

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
LBL-024 for Injection, Etoposide injection, Cisplatin injection - Advanced Extrapulmonary Neuroendocrine Carcinoma
Phase 3Not yet recruitingNanjing Leads Biolabs Co.,Ltd2802026-11-162026-10-19
ZG005 Plus Etoposide and Cisplatin vs. Etoposide and Cisplatin as First-Line Treatment for Advanced Neuroendocrine Carcinoma
ZG005 for Injection, Etoposide Injection, Cisplatin Injection - Neuroendocrine Carcinomas (NEC)
Phase 3Not yet recruitingSuzhou Zelgen Biopharmaceuticals Co.,Ltd4402026-10-012026-09-22
A Phase III, Randomized, Double-blind, Multi-center Trial Comparing Efficacy and Safety of Trilaciclib Versus Placebo in Participants With Limited-stage Small Cell Lung Cancer
Trilaciclib, Trilaciclib Placebo, Etoposide Injection - Myelosuppression
Phase 3Active not recruitingJiangsu Simcere Pharmaceutical Co., Ltd.1062026-06-172026-10-19
Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Ifupinostat Hydrochloride for Injection, Rituximab Injection, Gemcitabine Hydrochloride for Injection - Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 3RecruitingBeBetter Med Inc4162025-01-062026-08-19

Conditions studied

Carcinoma, Neuroendocrine (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Small Cell Lung Carcinoma (1)

Sponsors

BeBetter Med Inc (1)  ·  Jiangsu Simcere Pharmaceutical Co., Ltd. (1)  ·  Nanjing Leads Biolabs Co.,Ltd (1)  ·  Suzhou Zelgen Biopharmaceuticals Co.,Ltd (1)

Countries

China (4)

Top investigators

Lin Shen (1)  ·  Yuankai Shi, Phd (1)